The Board of Directors of Orogen Royalties Inc. has authorized the company’s annual equity-based compensation package, announcing grants to directors, officers, employees and consultants. In a move aligned with the firm’s incentive framework, the awards comprise 132,000 restricted share units (RSUs), 29,000 deferred share units (DSUs) and 618,000 incentive stock options. This action was taken under the company’s Omnibus Equity Incentive Compensation Plan, which shareholders approved on June 27, .
The grant details were disclosed in the press release dated February 13, , with regulatory acceptance from the TSX Venture Exchange pending.
The package is designed to align long-term shareholder and management interests by tying compensation to future company performance and retention. The use of a mix of time-based share units and options is intended to provide both deferred cashless value through units and potential upside through options, while standard vesting schedules and an exercise price frame the expected benefits and timelines for recipients.
Table of Contents:
Structure and vesting schedule of the awards
The awarded RSUs will fully vest on the second anniversary of the grant date, providing a two-year retention horizon for recipients. The granted DSUs include a staggered vesting schedule, vesting 50% on the third anniversary and the remaining 50% on the fourth anniversary, and are structured to settle upon termination of service. This makes DSUs particularly suited to long-term non-cash compensation for directors and senior executives who remain with the company over multiple years.
Concurrently, the incentive stock options have a term of five years and carry an exercise price of $3.12 per share. Vesting for the options occurs over a three-year period: 25% vests immediately on grant, then an additional 25% vests on each of the first, second and third anniversaries of the grant date. This graduated vesting strikes a balance between providing immediate ownership incentives and encouraging continued service to realize the full potential of the award.
Regulatory and corporate context
The issuance of these awards is conditional upon regulatory acceptance by the TSX Venture Exchange. The company confirmed that the grants were authorized under the previously shareholder-approved omnibus plan, which allows the board to allocate multiple forms of equity compensation in a coordinated manner. The plan provides flexibility to manage retention and reward across different roles and responsibilities, and aligns with common governance practices for publicly traded mining and royalty companies.
Relationship to existing portfolio and financing position
Orogen’s royalty portfolio focuses on organic royalty creation and targeted acquisitions on precious and base metal assets in western North America. Among the company’s notable holdings is a 2.0% NSR royalty on the Ermitaño gold and silver mine in Sonora, Mexico, which is operated by First Majestic Silver Corp. Management highlighted that Orogen remains well financed, with several projects actively being advanced by joint venture partners—factors that informed the board’s decisions on the size and structure of the compensation grants.
Governance, contacts and next steps
The announcement was made on behalf of the Board and signed by Paddy Nicol, President & CEO. For additional information, the company provided contact points including Paddy Nicol and Marco LoCascio, Vice President, Corporate Development, reachable at 604-248-8648. Corporate headquarters are listed as 1015 – 789 West Pender Street, Vancouver, BC, Canada V6C 1H2, and general inquiries may be directed to [email protected]. Investors and stakeholders are advised to monitor the company’s filings and the TSX Venture Exchange for regulatory acceptance and any related disclosures.
Implications for stakeholders
For shareholders, these awards are a standard corporate mechanism intended to preserve cash while motivating executives and directors through equity participation. For recipients, the mix of RSUs, DSUs, and stock options delivers a combination of deferred payout, long-term retention incentives, and potential capital appreciation. The defined vesting milestones and the fixed exercise price provide clarity on timing and potential economic outcome, subject to future share-price performance and regulatory confirmation.
Finally, the company encouraged interested parties to review the original press release and accompanying corporate materials for full terms and customary risk disclosures. The board’s approval of these awards underscores an ongoing effort to align compensation with long-term value creation across Orogen’s royalty assets and partnerships.
